Comment on cardiovascular events and androgen receptor signaling inhibitors in advanced prostate cancer-reply
Affiliation
Genito Urinary Cancer Research Group, Division of Cancer Sciences, University of Manchester, Manchester, England.Issue Date
2024
Metadata
Show full item recordCitation
El-Taji O, Sachdeva A. Comment on Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer-Reply. JAMA Oncol. 2024 Dec 1;10(12):1731-2. PubMed PMID: 39418043. Epub 2024/10/17. eng.Journal
JAMA OncologyDOI
10.1001/jamaoncol.2024.4584PubMed ID
39418043Additional Links
https://dx.doi.org/10.1001/jamaoncol.2024.4584Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1001/jamaoncol.2024.4584
Scopus Count
Collections
Related articles
- Comment on Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer.
- Authors: Tang Y, Wa Q, Huang S
- Issue date: 2024 Dec 1
- Adverse events in men with advanced prostate cancer treated with androgen biosynthesis inhibitors and androgen receptor inhibitors.
- Authors: Faraj KS, Oerline M, Kaufman SR, Dall C, Srivastava A, Caram MEV, Shahinian VB, Hollenbeck BK
- Issue date: 2024 Nov 1
- Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer: A Systematic Review and Meta-Analysis.
- Authors: El-Taji O, Taktak S, Jones C, Brown M, Clarke N, Sachdeva A
- Issue date: 2024 Jul 1
- Current androgen receptor antagonists under investigation for resistant prostate cancer.
- Authors: Nigro MC, Mollica V, Marchetti A, Cheng M, Rosellini M, Montironi R, Cheng L, Massari F
- Issue date: 2022 Feb
- Assessment of Cardiovascular Events Caused by New-Generation Androgen Receptor Pathway Inhibitors Used for Prostate Cancer: A Real-World Study in Japan.
- Authors: Masuda R, Noguchi Y, Aizawa H, Yoshizawa S, Nomura Y, Saguchi M, Iguchi K, Yoshimura T
- Issue date: 2025